Michael Roger Harrison, MD

Associate Professor of Medicine
Member of the Duke Cancer Institute
Email address michael.harrison@duke.edu

Education and Training

  • residency, Medicine, Tulane University, 2004 - 2007
  • M.D., Tulane University, 2004

Grants

Publications

Zhang, Tian, Julie Kephart, Elizabeth Bronson, Monika Anand, Christine Daly, Ivan Spasojevic, Subha Bakthavatsalam, et al. “Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.” Prostate 82, no. 7 (May 2022): 858–66. https://doi.org/10.1002/pros.24329.

PMID
35286730
Full Text

Hanson, Erik D., Mohamdod Alzer, Jackson Carver, Cameron K. Stopforth, Alexander R. Lucas, Young E. Whang, Matthew I. Milowsky, et al. “Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer.” Prostate Cancer Prostatic Dis, March 19, 2022. https://doi.org/10.1038/s41391-022-00523-8.

PMID
35306542
Full Text

Brown, Landon C., Susan Halabi, Jason A. Somarelli, Michael Humeniuk, Yuan Wu, Taofik Oyekunle, Lauren Howard, et al. “A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.” Prostate Cancer Prostatic Dis, March 15, 2022. https://doi.org/10.1038/s41391-022-00524-7.

PMID
35292724
Full Text

Harrison, Michael R., Paul G. Davis, Michel G. Khouri, David B. Bartlett, Rajan T. Gupta, Andrew J. Armstrong, Megan A. McNamara, et al. “A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND).” Prostate Cancer Prostatic Dis 25, no. 1 (March 2022): 58–64. https://doi.org/10.1038/s41391-022-00519-4.

PMID
35273377
Full Text

Costello, Brian A., Nrupen A. Bhavsar, Yousef Zakharia, Sumanta K. Pal, Ulka Vaishampayan, Heather Jim, Mayer N. Fishman, et al. “A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.” Clin Genitourin Cancer 20, no. 1 (February 2022): 1–10. https://doi.org/10.1016/j.clgc.2021.07.002.

PMID
34364796
Full Text

Tykodi, Scott S., Lucio N. Gordan, Robert S. Alter, Edward Arrowsmith, Michael R. Harrison, Ivor Percent, Rakesh Singal, et al. “Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.” J Immunother Cancer 10, no. 2 (February 2022). https://doi.org/10.1136/jitc-2021-003844.

PMID
35210307
Full Text

Hirsch, Laure, Nieves Martinez Chanza, Subrina Farah, Wanling Xie, Ronan Flippot, David A. Braun, Nityam Rathi, et al. “Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma.” Jama Oncol 7, no. 12 (December 1, 2021): 1815–23. https://doi.org/10.1001/jamaoncol.2021.4544.

PMID
34673916
Full Text

Bitting, Rhonda L., Patrick Healy, Daniel J. George, Monika Anand, Sung Kim, Tina Mayer, Carol Winters, et al. “Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial.” Eur Urol Oncol 4, no. 6 (December 2021): 948–54. https://doi.org/10.1016/j.euo.2020.01.005.

PMID
32063492
Full Text

Dzimitrowicz, Hannah, Elizabeth Esterberg, LaStella Miles, Giovanni Zanotti, Azah Borham, and Michael R. Harrison. “Referral and adjuvant treatment patterns after nephrectomy in high-risk locoregional renal cell carcinoma.” Cancer Med 10, no. 24 (December 2021): 8891–98. https://doi.org/10.1002/cam4.4407.

PMID
34751002
Full Text

Autio, Karen A., Emmanuel S. Antonarakis, Tina M. Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan, Michael J. Morris, et al. “Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.” Eur Urol Open Sci 34 (December 2021): 70–78. https://doi.org/10.1016/j.euros.2021.09.015.

PMID
34934969
Full Text

Pages